This work is licensed under a Creative Commons Attribution 4.0 International License.
| DRACP ID | Peptide Name | Sequence | Sequence Length | Origin |
|---|---|---|---|---|
| DRACP00256 | A12L/A20L/A23L | KWKSFLKTFKSLKKTVLHTLLKLISS | 26 | PeptideV13K |
| DRACP00281 | LTX-302 | WKKWXKKWK | 9 | Synthetic |
| DRACP00282 | LTX-315 | KKWWKKWXK | 9 | Synthetic |
| DRACP00283 | LTX-318 | XXWXXXWWX | 9 | Synthetic |
| DRACP00340 | MAC1/2 | AFGMALKLLKKVL | 13 | Synthetic |
| DRACP00341 | MAC1/26 | GFGMAXKLLKKVL | 13 | Synthetic |
| DRACP00342 | MAC1/25 | GFGMALKXLKKVL | 13 | Synthetic |
| DRACP00343 | MAC1/24 | GFGMALKLXKKVL | 13 | Synthetic |
| DRACP00344 | MAC1 | GFGMALKLLKKVL | 13 | Macropins and their analogs |
| DRACP00345 | MAC1/1 | gfgmalkllkkvl | 13 | Synthetic |
| DRACP00346 | MAC1/16 | GFGMALKLlKKVL | 13 | Synthetic |
| DRACP00347 | MAC1/19 | GFGmALKLLKKVL | 13 | Synthetic |
| DRACP00348 | MAC1/4 | GFGMaLKLLKKVL | 13 | Synthetic |
| DRACP00349 | MAC1/6 | GfGMALKLLKKVL | 13 | Synthetic |
| DRACP00350 | MAC1/20 | GFGMALXLLXXVL | 13 | Synthetic |
| DRACP00351 | MAC1/21 | GFGMALRLLRRVL | 13 | Synthetic |
| DRACP00352 | MAC1/10 | GFkMALKLLKKVL | 13 | Synthetic |
| DRACP00353 | MAC1/9 | GFKMALKLLKKVL | 13 | Synthetic |
| DRACP00354 | HAL-2/24 | GKFMSLLKHILK | 12 | Synthetic |
| DRACP00355 | HAL-1/19 | GKWKKILGHLIR | 12 | Synthetic |
| DRACP00356 | HAL-1/21 | GKWKKILGKLIR | 12 | Synthetic |
| DRACP00357 | HAL-2/1 | GKWKSLLKHILK | 12 | Synthetic |
| DRACP00358 | HAL-2/11 | GKWLSLLKHILK | 12 | Synthetic |
| DRACP00359 | HAL-2/2 | GKWMKLLKHILK | 12 | Synthetic |
| DRACP00360 | HAL-1/15 | GMWSKLLGHLLR | 12 | Synthetic |
| DRACP00361 | MAC2 | GTGLPMSERRKIMLMMR | 17 | Synthetic |
| DRACP00362 | HAL-1/17 | KMWSKILGHLIR | 12 | Synthetic |
| DRACP00363 | LL-III/22 | KNWKKXLKKXIKXVK | 15 | Synthetic |
| DRACP00364 | LL-III/10 | KNWKKILGKIIKVVK | 15 | Synthetic |
| DRACP00365 | LL-III/18 | KNWKKILKKIIKVVK | 15 | Synthetic |
This work is licensed under a Creative Commons Attribution 4.0 International License.